Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 23% ± 9% | |
GABAergic neuron | 4 studies | 37% ± 22% | |
astrocyte | 4 studies | 33% ± 11% | |
oligodendrocyte | 4 studies | 26% ± 7% | |
adipocyte | 4 studies | 19% ± 2% | |
interneuron | 4 studies | 36% ± 20% | |
microglial cell | 3 studies | 21% ± 3% | |
epithelial cell | 3 studies | 28% ± 3% | |
hepatocyte | 3 studies | 51% ± 21% | |
glutamatergic neuron | 3 studies | 52% ± 24% | |
endothelial cell of lymphatic vessel | 3 studies | 18% ± 2% | |
fibroblast | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 38% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2275.04 | 1445 / 1445 | 100% | 9.49 | 183 / 183 |
intestine | 100% | 2524.40 | 966 / 966 | 100% | 8.03 | 527 / 527 |
prostate | 100% | 2317.74 | 245 / 245 | 100% | 8.40 | 502 / 502 |
skin | 100% | 2523.28 | 1809 / 1809 | 100% | 13.64 | 472 / 472 |
breast | 100% | 2420.82 | 459 / 459 | 100% | 10.24 | 1115 / 1118 |
bladder | 100% | 2390.29 | 21 / 21 | 100% | 7.66 | 502 / 504 |
thymus | 100% | 2441.18 | 653 / 653 | 100% | 9.06 | 602 / 605 |
stomach | 100% | 2048.28 | 359 / 359 | 99% | 8.88 | 283 / 286 |
brain | 100% | 1938.78 | 2632 / 2642 | 99% | 11.32 | 700 / 705 |
uterus | 100% | 2764.54 | 170 / 170 | 99% | 7.80 | 454 / 459 |
lung | 100% | 2498.66 | 578 / 578 | 98% | 8.46 | 1137 / 1155 |
pancreas | 100% | 1419.98 | 328 / 328 | 98% | 6.66 | 174 / 178 |
kidney | 100% | 1678.57 | 89 / 89 | 97% | 6.70 | 874 / 901 |
ovary | 100% | 2502.05 | 180 / 180 | 96% | 7.07 | 414 / 430 |
liver | 100% | 1850.70 | 226 / 226 | 96% | 5.38 | 389 / 406 |
adrenal gland | 100% | 2258.02 | 258 / 258 | 95% | 5.94 | 219 / 230 |
adipose | 100% | 2201.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2088.26 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.55 | 29 / 29 |
muscle | 100% | 1550.05 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2541.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.01 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.30 | 1 / 1 |
heart | 99% | 1294.06 | 850 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 4.98 | 78 / 80 |
peripheral blood | 79% | 1184.54 | 737 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006338 | Biological process | chromatin remodeling |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0140658 | Molecular function | ATP-dependent chromatin remodeler activity |
GO_0004386 | Molecular function | helicase activity |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | RAD54L2 |
Protein name | Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2) RAD54 like 2 |
Synonyms | KIAA0809 ARIP4 |
Description | FUNCTION: DNA helicase that modulates androgen receptor (AR)-dependent transactivation in a promoter-dependent manner. Not able to remodel mononucleosomes in vitro (By similarity). . |
Accessions | Q9Y4B4 ENST00000409535.6 ENST00000432863.1 ENST00000684192.1 H0Y760 |